Provider Perspective on Access to Prescribed CLL Treatments

This anonymous and confidential survey is being conducted by CLL Society and ACCC in an effort to better understand provider experiences in the treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL).

When completing the survey, please answer based on your experience treating patients with CLL/SLL during the past two years. If your answers vary by drug or line of therapy, please provide a brief explanation in Question 20.

This survey should take 5-7 minutes to complete. Thank you in advance for sharing your feedback. You may access the brief survey by clicking on the Start button below.

Custom Title